EMERYVILLE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, and Michael P. Smith, Executive Vice President, Chief Financial Officer, Treasurer and Secretary, will provide a corporate update at the Bank of America Merrill Lynch 2018 Healthcare Conference, being held in Las Vegas, NV, from May 15-17, 2018.
| Bank of America Merrill Lynch 2018 Healthcare Conference – Zogenix Presentation Details | |
| Date: | Thursday, May 17, 2018 |
| Time: | 12:20 pm Eastern Time / 9:20 am Pacific Time |
| Location: | Las Vegas, NV – Encore Hotel |
The presentation will be webcast live and archived for 90 days on Zogenix's Investor Relations website at www.zogenix.com.
About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
For more information, visit www.zogenix.com.
CONTACT:
Investors:
Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987
Andrew@LifeSciAdvisors.com